A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in Germany

01/10/2015
08/07/2024
EU PAS number:
EUPAS11145
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

16159_GePaRD_Rivaroxaban protocol

English (601.88 KB - PDF) View document
Study results
Study results

Abstract_FinalReport

English (346.53 KB - PDF) View document
Study report
Study report

16159_Progress report_v1.0_2019-01-28

English (94.9 KB - PDF) View document

PASS_report_Germany_1Dec2020

English (8 MB - PDF) View document
Other information
Study, other information

PASS_report_Germany_1Dec2020.pdf

English (8 MB - PDF) View document
Publications
Study publications
Jobski K, Enders D, Amann U, Suzart K, Wallander MA, Schink T, Garbe E. Use of …